We further explored the relationship between IGF2BP3 and immune modulation, and found that IGF2BP3 was highly expressed in HCC immune subtypes C1 (wound healing), and C2(IFN-gamma dominant) via TISIDB (Figure 6D). This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.